Health Canada
www.hc-sc.gc.ca
Common menu bar links
Food and Nutrition
Appendix 11
Impact of Modifying the Trans Fat Content of Foods on Dietary Intakes
1. This report documents the estimation of usual intake distributions for various Trans Fat scenarios developed for the Trans Fat Task Force. It supplements previous documents Nutrient Sources 17 May 2005.doc, Vitamin D 1 Day Intake 30 May 2005 and Usual Intake Distributions 10 June 2005.doc which describe trans fat nutrient sources, one-day and usual intake statistics.
2. For this modelling, data files from three Federal-Provincial adult nutrition surveys were used: Ontario (1997/98, 1187 respondents), Manitoba (1998/99, 1525 respondents) and British Columbia (1999, 1823 respondents). For children, data files from the Quebec Children Nutrition survey (1999, 1932 respondents) were used
3. Modelling levels for Trans fat were set as shown in Table 1. A list of the foods in each group can be obtained from Health Canada, Nutrition Evaluation Division. All Trans fat exceeding limits was reassigned to Saturated fat on an equivalent basis.
Top of PageTable 1: Modelling Limits for Trans Fat
| Scenario | Trans fat limits for | |||
|---|---|---|---|---|
| Dairy and Meat products | Fats and Oils | Ice cream and Ice milk | All other foods | |
| 5% Trans Fat Limit | No limits | 2% of total lipids | 5% of total lipids | 5% of total lipids |
| 4% Trans Fat Limit | No limits | 2% of total lipids | 5% of total lipids | 4% of total lipids |
| 3% Trans Fat Limit | No limits | 2% of total lipids | 5% of total lipids | 3% of total lipids |
4. The contribution of each group to the diet is shown in Table 2. For this table, one-day Trans fat intakes are summed for each group, then expressed as a percentage of total Trans fat intakes, for the baseline and under each scenario. For example, Dairy and Meat products contribute 18.6% of the total Trans fat in diets; for the first modelling scenario above, this percentage increases to 42.0% as the Trans fat intakes from other groups are reduced. The contribution for Total Saturated fats (TSat), Total Lipids and Total Energy are also shown in Table 2.
Table 2: Contribution of each group to the diet
| Dairy and Meat Products | Fats and Oils | Ice Cream and Ice Milk | All Other Foods | |
|---|---|---|---|---|
| (%) | (%) | (%) | (%) | |
| Trans @Baseline | 18.6 | 36.5 | 1.0 | 43.9 |
| Trans @5%Limit |
42.0 | 14.2 | 2.1 | 41.8 |
| Trans @4%Limit | 44.8 | 15.1 | 2.2 | 2.2 |
| Trans @3%Limit | 48.1 | 16.3 | 2.4 | 33.2 |
5. Modelling of the scenarios consisted of applying the above limits to the trans-fat content of foods consumed by each survey respondent, summing one-day trans fat intakes for each individual, and then adjusting for the intra-individual variability to estimate usual trans fat intake distributions resulting from each scenario. Note that adjustments for day-to-day variability were done using the SIDE software (Version 1.11 from Iowa State University Statistical Laboratory) for the estimation of usual intakes; and population weights were applied to obtain representative distributions. Note also that for the usual intake estimation, the 14 age-sex groups were pooled into 6 groups to avoid SIDE estimation failures from negative estimates of variance components.
6. Table 3 shows for each age-sex group the one-day means for the baseline Trans fats (Trans), and the Trans fat resulting from each scenario. Also, table 3 shows the Trans fat percentage of total lipids (Trans%ofLipid), and the trans fat contribution to total energy (Trans%ofEnergy), as a baseline and resulting from the scenarios above.
7. Table 4 shows the usual intake distributions estimated for Trans fat, Trans fat percentage of lipids, and Trans fat contribution to total energy, as a baseline and under the modelling scenarios.
Table 3: Average Daily Intakes
Sex=Males
| DRI Age-sex Group | |||||||
|---|---|---|---|---|---|---|---|
| M 6-8 | M 9-13 | M 14-18 | M 19-30 | M 31-50 | M 51-70 | M 71+ | |
| Trans @Baseline(g/d) | 5.6 | 6.6 | 8.8 | 6.6 | 6.1 | 4.7 | 4.7 |
| Trans @5%Limit | 2.4 | 3.0 | 3.7 | 2.9 | 2.7 | 2.1 | 1.9 |
| Trans @4%Limit | 2.3 | 2.8 | 3.5 | 2.7 | 2.5 | 2.0 | 1.8 |
| Trans @3%Limit | 2.1 | 2.6 | 3.2 | 2.5 | 2.3 | 1.8 | 1.7 |
| Trans%Oflipid @Baseline(%) | 7.0 | 7.0 | 7.5 | 6.5 | 6.4 | 5.7 | 6.2 |
| Trans%ofLipid @5%Limit | 3.1 | 3.1 | 3.1 | 2.9 | 2.8 | 2.6 | 2.5 |
| Trans%ofLipid @4%Limit | 2.9 | 2.9 | 2.9 | 2.7 | 2.6 | 2.4 | 2.4 |
| Trans%ofLipid @3%Limit | 2.7 | 2.7 | 2.7 | 2.5 | 2.5 | 2.3 | 2.3 |
| Trans%Ofenergy @Baseline(%) | 2.2 | 2.2 | 2.4 | 2.0 | 2.0 | 1.8 | 2.0 |
| Trans%ofEnergy @5%Limit | 1.0 | 1.0 | 1.0 | 0.9 | 0.9 | 0.8 | 0.8 |
| Trans%ofEnergy @4%Limit | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.7 |
| Trans%ofEnergy @3%Limit | 0.8 | 0.9 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 |
Sex=Females
| DRI Age-sex Group | |||||||
|---|---|---|---|---|---|---|---|
| F 6-8 | F 9-13 | F 14-18 | F 19-30 | F 31-50 | F 51-70 | F 71+ | |
| Trans @Baseline(g/d) | 4.9 | 5.5 | 5.4 | 4.8 | 4.2 | 3.3 | 3.3 |
| Trans @5%Limit | 2.2 | 2.4 | 2.3 | 2.1 | 1.8 | 1.5 | 1.4 |
| Trans @4%Limit | 2.1 | 2.2 | 2.1 | 1.9 | 1.7 | 1.4 | 1.3 |
| Trans @3%Limit | 1.9 | 2.1 | 2.0 | 1.8 | 1.6 | 1.4 | 1.2 |
| Trans%Oflipid @Baseline(%) | 6.9 | 7.1 | 7.1 | 7.0 | 6.3 | 5.6 | 6.3 |
| Trans%ofLipid @5%Limit | 3.1 | 3.1 | 3.0 | 3.0 | 2.8 | 2.6 | 2.7 |
| Trans%ofLipid @4%Limit | 2.9 | 2.9 | 2.8 | 2.8 | 2.6 | 2.5 | 2.5 |
| Trans%ofLipid @3%Limit | 2.7 | 2.6 | 2.6 | 2.5 | 2.5 | 2.3 | 2.4 |
| Trans%Ofenergy @Baseline(%) | 2.2 | 2.2 | 2.2 | 2.1 | 2.0 | 1.7 | 1.9 |
| Trans%ofEnergy @5%Limit | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 |
| Trans%ofEnergy @4%Limit | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.7 |
| Trans%ofEnergy @3%Limit | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 |
Table 4: Usual Intake Distribution Results
| PERCENTILES | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0.1 | 0.2 | 0.3 | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | 0.95 | |
| Male 6-18 | ||||||||||
| TRANS Baseline (g/d) | 4.6 | 5.4 | 6.0 | 6.6 | 7.2 | 7.7 | 8.4 | 9.2 | 10.5 | 11.6 |
| TRANS @5%Limit (g/d) | 2.1 | 2.4 | 2.6 | 2.8 | 3.0 | 3.2 | 3.5 | 3.8 | 4.2 | 4.6 |
| Trans @4%Limit (g/d) | 2.0 | 2.2 | 2.4 | 2.6 | 2.8 | 3.0 | 3.2 | 3.5 | 3.9 | 4.3 |
| Trans @3%Limit (g/d) | 1.8 | 2.0 | 2.2 | 2.4 | 2.6 | 2.8 | 3.0 | 3.2 | 3.6 | 4.0 |
| Trans%ofLipid Baseline(%) | 5.9 | 6.4 | 6.8 | 7.1 | 7.4 | 7.7 | 8.0 | 8.4 | 9.0 | 9.5 |
| Trans%ofLipid @5%Limit | 2.5 | 2.7 | 2.9 | 3.0 | 3.2 | 3.3 | 3.5 | 3.6 | 3.8 | 4.0 |
| Trans%ofLipid @4%Limit | 2.4 | 2.6 | 2.7 | 2.8 | 2.9 | 3.0 | 3.2 | 3.3 | 3.5 | 3.6 |
| Trans%ofLipid @3%Limit | 2.3 | 2.5 | 2.5 | 2.6 | 2.7 | 2.7 | 2.8 | 2.9 | 3.1 | 3.2 |
| Trans%ofEnergy Baseline (%) | 1.9 | 2.1 | 2.2 | 2.3 | 2.4 | 2.4 | 2.5 | 2.7 | 2.8 | 3.0 |
| Trans%ofEnergy @5%Limit | 0.7 | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 | 1.4 |
| Trans%ofEnergy @4%Limit | 0.7 | 0.8 | 0.8 | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 | 1.2 | 1.3 |
| Trans%ofEnergy @3%Limit | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 | 1.2 |
| Female 6-18 | ||||||||||
| TRANS Baseline (g/d) | 3.5 | 4.1 | 4.6 | 5.1 | 5.5 | 6.0 | 6.6 | 7.3 | 8.4 | 9.4 |
| TRANS @5%Limit (g/d) | 1.6 | 1.9 | 2.0 | 2.2 | 2.3 | 2.5 | 2.7 | 2.9 | 3.1 | 3.4 |
| Trans @4%Limit (g/d) | 1.5 | 1.7 | 1.9 | 2.0 | 2.2 | 2.3 | 2.4 | 2.6 | 2.9 | 3.1 |
| Trans @3%Limit (g/d) | 1.4 | 1.6 | 1.7 | 1.9 | 2.0 | 2.1 | 2.2 | 2.4 | 2.6 | 2.8 |
| Trans%ofLipid Baseline(%) | 6.2 | 6.4 | 6.6 | 6.8 | 7.0 | 7.1 | 7.3 | 7.5 | 7.8 | 8.0 |
| Trans%ofLipid @5%Limit | 2.4 | 2.6 | 2.7 | 2.8 | 3.0 | 3.1 | 3.2 | 3.4 | 3.6 | 3.7 |
| Trans%ofLipid @4%Limit | 2.2 | 2.4 | 2.6 | 2.7 | 2.8 | 2.9 | 3.0 | 3.1 | 3.3 | 3.5 |
| Trans%ofLipid @3%Limit | 2.1 | 2.2 | 2.4 | 2.5 | 2.5 | 2.6 | 2.7 | 2.8 | 3.0 | 3.2 |
| Trans%ofEnergy Baseline (%) | 1.7 | 1.9 | 2.0 | 2.2 | 2.3 | 2.4 | 2.5 | 2.7 | 2.9 | 3.2 |
| Trans%ofEnergy @5%Limit | 0.6 | 0.7 | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.2 | 1.3 | 1.4 |
| Trans%ofEnergy @4%Limit | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.2 | 1.3 |
| Trans%ofEnergy @3%Limit | 0.6 | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.2 |
| Male 19-50 | ||||||||||
| TRANS Baseline (g/d) | 2.9 | 3.7 | 4.3 | 5.0 | 5.6 | 6.2 | 7.0 | 7.9 | 9.4 | 10.8 |
| TRANS @5%Limit (g/d) | 1.4 | 1.8 | 2.0 | 2.3 | 2.6 | 2.9 | 3.2 | 3.6 | 4.2 | 4.8 |
| Trans @4%Limit (g/d) | 1.3 | 1.6 | 1.9 | 2.2 | 2.4 | 2.7 | 3.0 | 3.4 | 4.0 | 4.6 |
| Trans @3%Limit (g/d) | 1.2 | 1.5 | 1.8 | 2.0 | 2.2 | 2.5 | 2.8 | 3.2 | 3.7 | 4.3 |
| Trans%ofLipid Baseline(%) | 4.4 | 4.9 | 5.4 | 5.7 | 6.1 | 6.5 | 6.9 | 7.4 | 8.1 | 8.7 |
| Trans%ofLipid @5%Limit | 1.7 | 2.2 | 2.5 | 2.7 | 2.9 | 3.1 | 3.3 | 3.6 | 3.9 | 4.1 |
| Trans%ofLipid @4%Limit | 1.6 | 2.1 | 2.4 | 2.6 | 2.7 | 2.9 | 3.1 | 3.3 | 3.6 | 3.8 |
| Trans%ofLipid @3%Limit | 1.6 | 1.9 | 2.2 | 2.4 | 2.5 | 2.7 | 2.9 | 3.1 | 3.3 | 3.6 |
| Trans%ofEnergy Baseline (%) | 1.3 | 1.5 | 1.6 | 1.7 | 1.9 | 2.0 | 2.2 | 2.3 | 2.6 | 2.9 |
| Trans%ofEnergy @5%Limit | 0.4 | 0.6 | 0.7 | 0.8 | 0.9 | 0.9 | 1.0 | 1.2 | 1.3 | 1.5 |
| Trans%ofEnergy @4%Limit | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | 1.0 | 1.1 | 1.3 | 1.4 |
| Trans%ofEnergy @3%Limit | 0.4 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 1.0 | 1.2 | 1.3 |
| Female 19-50 | ||||||||||
| TRANS Baseline (g/d) | 2.1 | 2.7 | 3.1 | 3.5 | 4.0 | 4.4 | 5.0 | 5.8 | 7.0 | 8.0 |
| TRANS @5%Limit (g/d) | 1.0 | 1.3 | 1.5 | 1.7 | 1.8 | 2.0 | 2.2 | 2.5 | 2.8 | 3.2 |
| Trans @4%Limit (g/d) | 1.0 | 1.2 | 1.4 | 1.5 | 1.7 | 1.9 | 2.1 | 2.3 | 2.6 | 3.0 |
| Trans @3%Limit (g/d) | 0.9 | 1.1 | 1.3 | 1.4 | 1.6 | 1.7 | 1.9 | 2.1 | 2.5 | 2.8 |
| Trans%ofLipid Baseline(%) | 4.6 | 5.2 | 5.6 | 6.0 | 6.4 | 6.8 | 7.3 | 7.8 | 8.7 | 9.4 |
| Trans%ofLipid @5%Limit | 1.9 | 2.2 | 2.5 | 2.7 | 2.9 | 3.0 | 3.3 | 3.5 | 3.9 | 4.1 |
| Trans%ofLipid @4%Limit | 1.8 | 2.1 | 2.3 | 2.5 | 2.7 | 2.9 | 3.0 | 3.2 | 3.5 | 3.8 |
| Trans%ofLipid @3%Limit | 1.7 | 2.0 | 2.2 | 2.3 | 2.5 | 2.6 | 2.8 | 3.0 | 3.3 | 3.5 |
| Trans%ofEnergy Baseline (%) | 1.2 | 1.4 | 1.6 | 1.7 | 1.9 | 2.0 | 2.2 | 2.5 | 2.8 | 3.2 |
| Trans%ofEnergy @5%Limit | 0.4 | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | 1.0 | 1.1 | 1.3 | 1.4 |
| Trans%ofEnergy @4%Limit | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | 1.0 | 1.1 | 1.2 | 1.3 |
| Trans%ofEnergy @3%Limit | 0.4 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 1.0 | 1.1 | 1.2 |
| Male 51+ | ||||||||||
| TRANS Baseline (g/d) | 2.4 | 3.0 | 3.5 | 4.1 | 4.6 | 5.3 | 6.1 | 7.1 | 8.5 | 9.9 |
| TRANS @5%Limit (g/d) | 1.2 | 1.5 | 1.7 | 1.9 | 2.0 | 2.3 | 2.5 | 2.8 | 3.3 | 3.7 |
| Trans @4%Limit (g/d) | 1.1 | 1.4 | 1.6 | 1.7 | 1.9 | 2.1 | 2.4 | 2.6 | 3.1 | 3.5 |
| Trans @3%Limit (g/d) | 1.0 | 1.3 | 1.5 | 1.6 | 1.8 | 2.0 | 2.2 | 2.5 | 3.0 | 3.3 |
| Trans%ofLipid Baseline(%) | 3.8 | 4.5 | 5.0 | 5.5 | 6.0 | 6.5 | 7.1 | 7.8 | 8.8 | 9.7 |
| Trans%ofLipid @5%Limit | 1.7 | 2.0 | 2.2 | 2.4 | 2.5 | 2.8 | 3.0 | 3.2 | 3.6 | 3.8 |
| Trans%ofLipid @4%Limit | 1.6 | 1.9 | 2.1 | 2.2 | 2.4 | 2.6 | 2.8 | 3.0 | 3.3 | 3.5 |
| Trans%ofLipid @3%Limit | 1.5 | 1.8 | 2.0 | 2.1 | 2.3 | 2.4 | 2.6 | 2.8 | 3.1 | 3.3 |
| Trans%ofEnergy Baseline (%) | 1.0 | 1.3 | 1.4 | 1.6 | 1.8 | 2.0 | 2.2 | 2.5 | 2.9 | 3.2 |
| Trans%ofEnergy @5%Limit | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | 1.0 | 1.1 | 1.3 |
| Trans%ofEnergy @4%Limit | 0.4 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 1.0 | 1.1 | 1.2 |
| Trans%ofEnergy @3%Limit | 0.4 | 0.5 | 0.6 | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | 1.0 | 1.1 |
| Female 51+ | ||||||||||
| TRANS Baseline (g/d) | 1.6 | 2.0 | 2.3 | 2.6 | 3.0 | 3.3 | 3.7 | 4.2 | 5.0 | 5.7 |
| TRANS @5%Limit (g/d) | 0.9 | 1.0 | 1.2 | 1.3 | 1.4 | 1.5 | 1.7 | 1.9 | 2.2 | 2.5 |
| Trans @4%Limit (g/d) | 0.8 | 1.0 | 1.1 | 1.2 | 1.3 | 1.4 | 1.6 | 1.8 | 2.1 | 2.3 |
| Trans @3%Limit (g/d) | 0.7 | 0.9 | 1.0 | 1.1 | 1.2 | 1.4 | 1.5 | 1.7 | 1.9 | 2.2 |
| Trans%ofLipid Baseline(%) | 3.8 | 4.3 | 4.8 | 5.1 | 5.5 | 5.9 | 6.3 | 6.8 | 7.6 | 8.3 |
| Trans%ofLipid @5%Limit | 1.7 | 2.0 | 2.2 | 2.4 | 2.6 | 2.8 | 3.0 | 3.3 | 3.6 | 3.9 |
| Trans%ofLipid @4%Limit | 1.6 | 1.9 | 2.1 | 2.3 | 2.5 | 2.6 | 2.8 | 3.1 | 3.4 | 3.6 |
| Trans%ofLipid @3%Limit | 1.5 | 1.8 | 2.0 | 2.2 | 2.3 | 2.5 | 2.6 | 2.8 | 3.1 | 3.3 |
| Trans%ofEnergy Baseline (%) | 0.9 | 1.1 | 1.3 | 1.4 | 1.6 | 1.7 | 1.9 | 2.1 | 2.5 | 2.7 |
| Trans%ofEnergy @5%Limit | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | 0.9 | 1.1 | 1.2 | 1.3 |
| Trans%ofEnergy @4%Limit | 0.4 | 0.5 | 0.6 | 0.6 | 0.7 | 0.8 | 0.9 | 1.0 | 1.1 | 1.3 |
| Trans%ofEnergy @3%Limit | 0.4 | 0.4 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 1.1 | 1.2 |
Table 5: Standard Errors of Usual Intake Percentile Estimates
| STANDARD ERRORS OF PERCENTILES | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0.1 | 0.2 | 0.3 | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | 0.95 | |
| |Male 6-18 | ||||||||||
| TRANS Baseline (g/d) | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.4 | 0.6 |
| TRANS @5%Limit (g/d) | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 |
| Trans @4%Limit (g/d) | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 |
| Trans @3%Limit (g/d) | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 |
| Trans%ofLipid Baseline(%) | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.4 |
| Trans%ofLipid @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofLipid @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofLipid @3%Limit | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 |
| Trans%ofEnergy Baseline (%) | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Trans%ofEnergy @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @3%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Female 6-18 | ||||||||||
| TRANS Baseline (g/d) | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.5 |
| TRANS @5%Limit (g/d) | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Trans @4%Limit (g/d) | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Trans @3%Limit (g/d) | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Trans%ofLipid Baseline(%) | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 |
| Trans%ofLipid @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Trans%ofLipid @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Trans%ofLipid @3%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Trans%ofEnergy Baseline (%) | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Trans%ofEnergy @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @3%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Male 19-50 | ||||||||||
| TRANS Baseline (g/d) | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.5 | 0.7 |
| TRANS @5%Limit (g/d) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 |
| Trans @4%Limit (g/d) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Trans @3%Limit (g/d) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Trans%ofLipid Baseline(%) | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 |
| Trans%ofLipid @5%Limit | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Trans%ofLipid @4%Limit | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofLipid @3%Limit | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Trans%ofEnergy Baseline (%) | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 |
| Trans%ofEnergy @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @3%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Female 19-50 | ||||||||||
| TRANS Baseline (g/d) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.4 |
| TRANS @5%Limit (g/d) | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Trans @4%Limit (g/d) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Trans @3%Limit (g/d) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Trans%ofLipid Baseline(%) | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 |
| Trans%ofLipid @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofLipid @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofLipid @3%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy Baseline (%) | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 |
| Trans%ofEnergy @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @3%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Male 51+ | ||||||||||
| TRANS Baseline (g/d) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.5 |
| TRANS @5%Limit (g/d) | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 |
| Trans @4%Limit (g/d) | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 |
| Trans @3%Limit (g/d) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Trans%ofLipid Baseline(%) | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.4 |
| Trans%ofLipid @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Trans%ofLipid @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Trans%ofLipid @3%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Trans%ofEnergy Baseline (%) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 |
| Trans%ofEnergy @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @3%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Female 51+ | ||||||||||
| TRANS Baseline (g/d) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 |
| TRANS @5%Limit (g/d) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Trans @4%Limit (g/d) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Trans @3%Limit (g/d) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Trans%ofLipid Baseline(%) | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.3 |
| Trans%ofLipid @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Trans%ofLipid @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Trans%ofLipid @3%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy Baseline (%) | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Trans%ofEnergy @5%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @4%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Trans%ofEnergy @3%Limit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
